205 related articles for article (PubMed ID: 26934001)
21. miR-942 promotes cancer stem cell-like traits in esophageal squamous cell carcinoma through activation of Wnt/β-catenin signalling pathway.
Ge C; Wu S; Wang W; Liu Z; Zhang J; Wang Z; Li R; Zhang Z; Li Z; Dong S; Wang Y; Xue Y; Yang J; Tan Q; Wang Z; Song X
Oncotarget; 2015 May; 6(13):10964-77. PubMed ID: 25844602
[TBL] [Abstract][Full Text] [Related]
22. TM4SF1 promotes the self-renewal of esophageal cancer stem-like cells and is regulated by miR-141.
Xue L; Yu X; Jiang X; Deng X; Mao L; Guo L; Fan J; Fan Q; Wang L; Lu SH
Oncotarget; 2017 Mar; 8(12):19274-19284. PubMed ID: 27974706
[TBL] [Abstract][Full Text] [Related]
23. TGFBI Expression in Cancer Stromal Cells is Associated with Poor Prognosis and Hematogenous Recurrence in Esophageal Squamous Cell Carcinoma.
Ozawa D; Yokobori T; Sohda M; Sakai M; Hara K; Honjo H; Kato H; Miyazaki T; Kuwano H
Ann Surg Oncol; 2016 Jan; 23(1):282-9. PubMed ID: 25448803
[TBL] [Abstract][Full Text] [Related]
24. Negative expression of PTEN identifies high risk for lymphatic-related metastasis in human esophageal squamous cell carcinoma.
Sun Z; Ji N; Bi M; Zhang Z; Liu X; Wang Z
Oncol Rep; 2015 Jun; 33(6):3024-32. PubMed ID: 25963289
[TBL] [Abstract][Full Text] [Related]
25. RAB23, regulated by miR-92b, promotes the progression of esophageal squamous cell carcinoma.
Cheng L; Yang F; Zhou B; Yang H; Yuan Y; Li X; Han S
Gene; 2016 Dec; 595(1):31-38. PubMed ID: 27659550
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA-25 promotes cell migration and invasion in esophageal squamous cell carcinoma.
Xu X; Chen Z; Zhao X; Wang J; Ding D; Wang Z; Tan F; Tan X; Zhou F; Sun J; Sun N; Gao Y; Shao K; Li N; Qiu B; He J
Biochem Biophys Res Commun; 2012 May; 421(4):640-5. PubMed ID: 22450326
[TBL] [Abstract][Full Text] [Related]
27. Dual inhibition of cMET and EGFR by microRNA-338-5p suppresses metastasis of esophageal squamous cell carcinoma.
Cui D; Zhu Y; Yan D; Lee NPY; Han L; Law S; Tsao GSW; Cheung ALM
Carcinogenesis; 2021 Jul; 42(7):995-1007. PubMed ID: 34089582
[TBL] [Abstract][Full Text] [Related]
28. Low SOX17 expression is a prognostic factor and drives transcriptional dysregulation and esophageal cancer progression.
Kuo IY; Wu CC; Chang JM; Huang YL; Lin CH; Yan JJ; Sheu BS; Lu PJ; Chang WL; Lai WW; Wang YC
Int J Cancer; 2014 Aug; 135(3):563-73. PubMed ID: 24407731
[TBL] [Abstract][Full Text] [Related]
29. Fra-1 Regulates the Expression of HMGA1, Which is Associated with a Poor Prognosis in Human Esophageal Squamous Cell Carcinoma.
Toyozumi T; Hoshino I; Takahashi M; Usui A; Akutsu Y; Hanari N; Murakami K; Kano M; Akanuma N; Suitoh H; Matsumoto Y; Sekino N; Komatsu A; Matsubara H
Ann Surg Oncol; 2017 Oct; 24(11):3446-3455. PubMed ID: 27882471
[TBL] [Abstract][Full Text] [Related]
30. Downregulation of microRNA-92b-3p suppresses proliferation, migration, and invasion of gastric cancer SGC-7901 cells by targeting Homeobox D10.
Li C; Huo B; Wang Y; Cheng C
J Cell Biochem; 2019 Oct; 120(10):17405-17412. PubMed ID: 31106881
[TBL] [Abstract][Full Text] [Related]
31. Overexpression of Sirtuin-1 is associated with poor clinical outcome in esophageal squamous cell carcinoma.
He Z; Yi J; Jin L; Pan B; Chen L; Song H
Tumour Biol; 2016 Jun; 37(6):7139-48. PubMed ID: 26662958
[TBL] [Abstract][Full Text] [Related]
32. Methylation decreases the Bin1 tumor suppressor in ESCC and restoration by decitabine inhibits the epithelial mesenchymal transition.
Wang X; Wang J; Jia Y; Wang Y; Han X; Duan Y; Lv W; Ma M; Liu L
Oncotarget; 2017 Mar; 8(12):19661-19673. PubMed ID: 28152502
[TBL] [Abstract][Full Text] [Related]
33. Insulin receptor substrate-1 and Golgi phosphoprotein 3 are downstream targets of miR‑126 in esophageal squamous cell carcinoma.
Li H; Meng F; Ma J; Yu Y; Hua X; Qin J; Li Y
Oncol Rep; 2014 Sep; 32(3):1225-33. PubMed ID: 25017784
[TBL] [Abstract][Full Text] [Related]
34. miR-145, miR-133a and miR-133b: Tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma.
Kano M; Seki N; Kikkawa N; Fujimura L; Hoshino I; Akutsu Y; Chiyomaru T; Enokida H; Nakagawa M; Matsubara H
Int J Cancer; 2010 Dec; 127(12):2804-14. PubMed ID: 21351259
[TBL] [Abstract][Full Text] [Related]
35. [Mechanisms of the suppression of proliferation and invasion ability mediated by microRNA-147b in esophageal squamous cell carcinoma].
Tang Y; Li Z; Shi ZX
Zhonghua Yi Xue Za Zhi; 2018 Jul; 98(26):2092-2098. PubMed ID: 30032507
[No Abstract] [Full Text] [Related]
36. Increased expression of EIF5A2, via hypoxia or gene amplification, contributes to metastasis and angiogenesis of esophageal squamous cell carcinoma.
Li Y; Fu L; Li JB; Qin Y; Zeng TT; Zhou J; Zeng ZL; Chen J; Cao TT; Ban X; Qian C; Cai Z; Xie D; Huang P; Guan XY
Gastroenterology; 2014 Jun; 146(7):1701-13.e9. PubMed ID: 24561231
[TBL] [Abstract][Full Text] [Related]
37. Metastasis-suppressing NID2, an epigenetically-silenced gene, in the pathogenesis of nasopharyngeal carcinoma and esophageal squamous cell carcinoma.
Chai AW; Cheung AK; Dai W; Ko JM; Ip JC; Chan KW; Kwong DL; Ng WT; Lee AW; Ngan RK; Yau CC; Tung SY; Lee VH; Lam AK; Pillai S; Law S; Lung ML
Oncotarget; 2016 Nov; 7(48):78859-78871. PubMed ID: 27793011
[TBL] [Abstract][Full Text] [Related]
38. MiR-142-3p as a potential prognostic biomarker for esophageal squamous cell carcinoma.
Lin RJ; Xiao DW; Liao LD; Chen T; Xie ZF; Huang WZ; Wang WS; Jiang TF; Wu BL; Li EM; Xu LY
J Surg Oncol; 2012 Feb; 105(2):175-82. PubMed ID: 21882196
[TBL] [Abstract][Full Text] [Related]
39. MicroRNA and target mRNA selection through invasion and cytotoxicity cell modeling and bioinformatics approaches in esophageal squamous cell carcinoma.
Lu M; Song Y; Fu W; Liu Y; Huai S; Cui X; Pang L; Yang L; Wei Y
Oncol Rep; 2017 Aug; 38(2):1181-1189. PubMed ID: 28677800
[TBL] [Abstract][Full Text] [Related]
40. Altered miRNA expression is associated with differentiation, invasion, and metastasis of esophageal squamous cell carcinoma (ESCC) in patients from Huaian, China.
Fu HL; Wu DP; Wang XF; Wang JG; Jiao F; Song LL; Xie H; Wen XY; Shan HS; Du YX; Zhao YP
Cell Biochem Biophys; 2013 Nov; 67(2):657-68. PubMed ID: 23516093
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
